Sort   by:  
 Page size 
ProteomicsMachine learning for grading and prognosis of esophageal dysplasia using mass spectrometry and histological imaging
Background: Barrett’s esophagus (BE) is a precursor lesion of esophageal adenocarcinoma and may progress from non-dysplastic through low-grade dysplasia (LGD) to high-grade dysplasia (HGD) and cancer. Grading BE is of crucial prognostic value and is currently based on the subjective evaluation of bi...
ORGANISM(S): Homo sapiens (Human) 
2021-11-15 | PXD028949 | Pride
Deep learning Mass spectrometry imaging H&e staining Barrett’s esophagus Machine learning 
UnknownmTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment.
Not available
S-EPMC3832859 | biostudies-literature
UnknownA blended e-health intervention for improving functional capacity in elderly patients on haemodialysis: A feasibility study.
Not available
S-EPMC9763896 | biostudies-literature
UnknownCatalytic 1,2-dihydronaphthalene and E-aryl-diene synthesis via CoIII-Carbene radical and o-quinodimethane intermediates.
Not available
S-EPMC5857932 | biostudies-literature
UnknownPirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.
Not available
S-EPMC12686794 | biostudies-literature
GenomicsE2F7 represses a transcriptional network of oscillating cell cycle genes to control S-phase progression.
E2F transcription factors are known to be important for timely activation of G1/S and G2/M genes required for cell cycle progression, but transcriptional mechanisms for deactivation of cell cycle regulated genes are unknown. Here, we show that E2F7 is highly expressed during mid to late S-phase, occ...
ORGANISM(S): Homo sapiens 
2012-01-04 | E-GEOD-32673 | biostudies-arrayexpress
UnknownThe INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility.
Not available
S-EPMC2804565 | biostudies-literature
UnknownEvaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy.
Not available
S-EPMC11474313 | biostudies-literature
UnknownPirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Not available
S-EPMC11758240 | biostudies-literature
UnknownDiscriminative ability of instrumented cognitive-motor assessments to distinguish fallers from non-fallers.
Not available
S-EPMC11872953 | biostudies-literature
Sort   by:  
 Page size